Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

5Total

Not Applicable (3)

P 1 (1)

P 4 (1)

Trial Status

Recruiting2

Completed1

Not Yet Recruiting1

Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (5)

Showing 5 of 5 trials

NCT07407894Not ApplicableRecruiting

iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults

NCT07089381Not ApplicableRecruiting

Efficacy and Safety of Resveratrol in Patients With Rheumatoid Arthritis.

NCT07068061Not ApplicableNot Yet Recruiting

PER-SAF_PDOS (Performance and Safety of Polydioxanone Suture)

NCT05813379Phase 1UnknownPrimary

Mesenchymal Stem Cells Derived Exosomes in Skin Rejuvenation

NCT01598272Phase 4CompletedPrimary

Effects of a Proprietary Blend of Herbal Extract Supplement on Cellular Detoxification, Inflammation, and Cumulative Cognitive Index as Well as Gene Expression in Middle-Aged Adult Women

Showing all 5 trials

Anti Aging